proline and Fibroma

proline has been researched along with Fibroma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balducci, C; Becchetti, E; Calastrini, C; Carinci, F; Dolci, C; Lilli, C; Locci, P; Lumare, E; Marinucci, L; Stabellini, G	1

Other Studies

1 other study(ies) available for proline and Fibroma

Article	Year
Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2008, Volume: 62, Issue:7 Topics: Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Collagen; Fibroblasts; Fibroma; Fibromatosis, Aggressive; Fibronectins; Glycosaminoglycans; Humans; Proline; Protein Serine-Threonine Kinases; Proteoglycans; Receptor, Transforming Growth Factor-beta Type I; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; RNA; Selective Estrogen Receptor Modulators; Toremifene; Transforming Growth Factor beta1	2008

Article

Year

Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2008, Volume: 62, Issue:7

Topics: Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Collagen; Fibroblasts; Fibroma; Fibromatosis, Aggressive; Fibronectins; Glycosaminoglycans; Humans; Proline; Protein Serine-Threonine Kinases; Proteoglycans; Receptor, Transforming Growth Factor-beta Type I; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; RNA; Selective Estrogen Receptor Modulators; Toremifene; Transforming Growth Factor beta1

2008